
Clairyon is a leader in AI-powered multimodal intelligence, providing clinical intelligence solutions that deliver real-time insights to healthcare providers. Their products, including GenAI solutions, focus on improving patient outcomes by predicting adverse events and enhancing hospital quality reporting. With a strong emphasis on early detection and efficient reporting, Clairyon has demonstrated significant traction, helping over 200,000 patients and monitoring more than 62 care units. Their commitment to HIPAA compliance and SOC 2 Type II standards positions them as a trusted partner in the healthcare industry.

Clairyon is a leader in AI-powered multimodal intelligence, providing clinical intelligence solutions that deliver real-time insights to healthcare providers. Their products, including GenAI solutions, focus on improving patient outcomes by predicting adverse events and enhancing hospital quality reporting. With a strong emphasis on early detection and efficient reporting, Clairyon has demonstrated significant traction, helping over 200,000 patients and monitoring more than 62 care units. Their commitment to HIPAA compliance and SOC 2 Type II standards positions them as a trusted partner in the healthcare industry.
Headquarters: San Diego, California, United States
Founded: 2021
Focus: AI-powered multimodal clinical intelligence, outpatient monitoring, predictive analytics, quality reporting
Employees: 1–10
Notable funding: Grant round (Jun 24, 2024) funded by National Institute of Allergy and Infectious Diseases
Healthcare AI for patient monitoring, early detection of adverse events, and quality reporting
2021
Healthcare technology